Clinical Trial Update: Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/IIa trial update for a folate binding protein vaccine in ovarian cancer, with completed status across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Folate binding protein vaccine

Snippet

Sponsor: COL George Peoples, MD, FACS | Conditions: Ovarian Cancer, Endometrial Cancer | Phase 1, Phase 2 | Status: COMPLETED